Keyphrases
Antiretroviral
100%
HPV16
100%
Highly Active Antiretroviral Therapy (HAART)
100%
Protease Inhibitors
100%
Retroviral Protease
100%
Oral Epithelium
100%
Cervical Epithelium
100%
Papillomavirus Infections
60%
Epithelium
40%
Oral Cancer
40%
AIDS/HIV
40%
Cervical Cancer
40%
Novel Class
20%
Epidemiology Study
20%
Tissue Culture Model
20%
Improved Survival
20%
Bromodeoxyuridine
20%
Virus Persistence
20%
Nave
20%
High-risk Human Papillomavirus (HR-HPV)
20%
Viral Load
20%
Cancer Development
20%
Antiviral Drugs
20%
Basal Layer
20%
Infected Patients
20%
Mechanistic Role
20%
New Infections
20%
Cell-cell Junctions
20%
Stratified Epithelium
20%
Human Cervical Spine
20%
Inhibitor Treatment
20%
In Vitro Tissue Culture
20%
Paracellular Permeability
20%
Three-dimensional Tissue
20%
Cervical Epithelial Cells
20%
Medicine and Dentistry
Infection
100%
Proteinase Inhibitor
100%
Highly Active Antiretroviral Therapy
100%
Human Papillomavirus Type 16
100%
Papillomavirus Infection
60%
Oral Cancer
40%
Human Immunodeficiency Virus
40%
Wart Virus
40%
Cervical Cancer
40%
In Vitro
20%
Epithelial Cell
20%
Cohort Effect
20%
Cancer
20%
Bromodeoxyuridine
20%
Basement Membrane
20%
Gum (Oral Cavity)
20%
Cell Junction
20%
Persistent Virus Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Human Papillomavirus Type 16
100%
Proteinase Inhibitor
100%
Papillomavirus Infection
100%
Mouth Cancer
66%
HIV
66%
Human Papillomavirus
66%
Uterine Cervix Cancer
66%
Broxuridine
33%
Persistent Virus Infection
33%
Immunology and Microbiology
Wart Virus
100%
Human Papillomavirus Type 16
100%
Human Immunodeficiency Virus
40%
Viral Load
20%
Tissue Culture
20%
Gingiva
20%
Basement Membrane
20%
Cell Junction
20%
Virus
20%